Please try another search
CAMBRIDGE, UK - The U.S. Food and Drug Administration (FDA) has approved AstraZeneca (NASDAQ:AZN)'s FluMist, a needle-free nasal spray influenza vaccine, for self-administration at home for adults up...
Investing.com -- Shares of AstraZeneca (LON:AZN) dropped on Thursday following the presentation of disappointing final overall survival data from the TROPION-Lung-01 (TL-01) trial at the World...
LOS ANGELES, CA - Puma Biotechnology, Inc. (NASDAQ:PBYI) faced a mixed outcome in its patent infringement lawsuit against AstraZeneca (NASDAQ:AZN) Pharmaceuticals LP, as a federal judge ruled on...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review